Skip to main content
SpringerLink
Log in

Indications and General Pathology of Liver Transplantation Candidates

  • Chapter
Diagnostic and Interventional Radiology in Liver Transplantation

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 216 Accesses

Abstract

Due to the availability of very potent immunosup- pressive drugs and to refinements in surgical techniques, the results of liver transplantation have improved during the last decade. Currently, liver transplantation is a widely accepted effective therapeutic modality for a variety of irreversible acute and chronic liver diseases, offering 1- and 5-year patient survival rates of approximately 70%-90% and 50%-70%, respectively. With these achievements the indication criteria for liver transplantation have been expanded and the number of transplantations being performed has increased. However, nowadays the supply of grafts cannot meet the needs, so that the number of patients on the waiting list is steadily growing. This underscores the importance of establishing strict, generally accepted guidelines for the selection of liver transplant recipients. In addition, the prolonged waiting period for a graft makes optimal timing of liver transplantation more difficult. In the future, it will probably be necessary to put patients on the waiting list before they actually need an organ to ensure future availability of a graft.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, Brown N, Condreay LD (1998) Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27:1670–1677

    Article  PubMed  CAS  Google Scholar 

  • Anand A, Ferraz-Neto B, Nightingale P, Mirza D, White A, McMaster P (1997a) Liver transplantation for alcoholic liver disease: evaluation of a selection protocol. Hepatology 25:1478–1484

    Article  PubMed  CAS  Google Scholar 

  • Anand AC, Nightingale P, Neuberger JM (1997b) Early indicators of prognosis in fulminant hepatic failure: an assessment of the King’s criteria. J Hepatol 26:62–68

    Article  PubMed  CAS  Google Scholar 

  • Ascher NL, Lake JR, Emond JC, Roberts JP (1993) Liver transplantation for fulminant hepatic failure. Arch Surg 128:677–682

    Article  PubMed  CAS  Google Scholar 

  • Ascher NL, Lake J, Emond J, Roberts J (1994) Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 20:24S–27S

    PubMed  CAS  Google Scholar 

  • Bax R, Hassler A, Luck W, Hefter H, Krageloh-Mann I, Neuhaus P, Emmrich P (1998) Cerebral manifestation of Wilson’s disease successfully treated with liver transplantation. Neurology 51(3):863–865

    Article  PubMed  CAS  Google Scholar 

  • Bellary S, Hassanein T, Van Thiel D (1995) Liver transplantation for Wilson’s disease. J Hepatol 23(4):373–381

    Article  PubMed  CAS  Google Scholar 

  • Berlakovich G, Steininger R, Herbst F, Barla M, Mittlbock M, Muhlbacher F (1994) Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance. Transplantation 58:560–565

    Article  PubMed  CAS  Google Scholar 

  • Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, Degott C et al (1986) Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6:648–651

    Article  PubMed  CAS  Google Scholar 

  • Bismuth H, Sherlock D (1991) Portosystemic shunting versus liver transplantation for the Budd Chiari syndrome. Ann Surg 214:581–589

    Article  PubMed  CAS  Google Scholar 

  • Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP (1996) Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 16:415–425

    Article  PubMed  CAS  Google Scholar 

  • Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, and Baulieux J (1997) Pilot study of the combination of with interferon alpha and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 26:500–504

    Article  PubMed  CAS  Google Scholar 

  • Blum U, Rössle M, Haag K et al (1995) Budd-Chiari syndrome-technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology 197:805–811

    PubMed  CAS  Google Scholar 

  • Boker K, Dalley G, Bahr M, Maschek H, Tillmann H, Trautwein C (1997) Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 25:203–210

    PubMed  CAS  Google Scholar 

  • Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cho-langitis. Gut 38:610–615

    Article  PubMed  CAS  Google Scholar 

  • Burdelski M, Rodeck B, Latta A et al (1991) Treatment of inherited metabolic disorders by liver transplantation. J Inherit Metab Dis 14:604–618

    Article  PubMed  CAS  Google Scholar 

  • Christensen E, Neuberger J, Crowe J, Altman D, Popper H, Portmann B, Doniach D (1985) Beneficial effect of aza-thioprine and prediction of prognosis in primary biliary cirrhosis: final result of an international trial. Gastroen-terology 89:1084–1091

    CAS  Google Scholar 

  • Dickson E, Grambsch P, Fleming T, Fisher L, Langworthy A (1989) Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10:1–7

    Article  PubMed  CAS  Google Scholar 

  • Dickson E, Murtaugh P, Wiesner R, Grambsch P, Fleming T, Ludwig J (1992) Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 103:1893–1901

    PubMed  CAS  Google Scholar 

  • Dickson R, Caldwell S, Ishitani M, Lau J, Driscoll V, Stevenson W (1996) Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 61:701–705

    Article  PubMed  CAS  Google Scholar 

  • Farrant J, Hayllar K, Wilkinson M, Kavani J, Portman B, Westaby D, William R (1991) Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100:1710–1717

    PubMed  CAS  Google Scholar 

  • Farrell F, Nguyen M, Woodley S et al (1994) Outcome of liver transplantation in patients with hemochromatosis. Hepatology 20:404–410

    Article  PubMed  CAS  Google Scholar 

  • Fattovich G, Giustina G, Schalm S (1995) Occurrence of hepa-tocellular carcinoma and decompensation in Western European patients with cirrhosis type B. Hepatology 21:77–82

    PubMed  CAS  Google Scholar 

  • Fattovich G, Giustina G, Degos F (1997) Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112:463–472

    Article  PubMed  CAS  Google Scholar 

  • Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13(4):399–408

    Article  PubMed  CAS  Google Scholar 

  • Feray C, Samuel D, Gigou M, Paradis V, David M, Lemonnier C (1995) An open trial of interferon alpha recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 22:1084–1089

    Article  PubMed  CAS  Google Scholar 

  • Fischer L, Sterneck M, Rogiers X (1999a) Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation. Transplant Proc 32:2128–2130

    Article  Google Scholar 

  • Fischer L, Sterneck M, Valentin-Gamazo C, Feucht HH, Malagó M, and Broelsch CE (1999b) Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha. Transplant Proc 31:494–495

    Article  PubMed  CAS  Google Scholar 

  • Foster P, Fabrega F, Karademir S, Sankary H, Mital D, Williams J (1997) Prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Hepatology 25:1469–1477

    Article  PubMed  CAS  Google Scholar 

  • Gane E, Portmann B, Naoumov N, Smith H, Underhill J, Donaldson P (1996) Long term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334:815–820

    Article  PubMed  CAS  Google Scholar 

  • Gordon F, Poterucha J, Germer J, Zein N, Batts K, Gross J (1997) Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 63:1419–1423

    Article  PubMed  CAS  Google Scholar 

  • Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, Stribling RJ, Goldstein LI, Busuttil RW (1997) Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 225(5):472–481

    Article  PubMed  CAS  Google Scholar 

  • Grambsch P, Dickson E, Kaplan M, LeSage G, Fleming T, Langworthy A (1989) Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability. Hepatology 10:846–850

    Article  PubMed  CAS  Google Scholar 

  • Greenson J, Svoboda-Newman S, Merlon R, Frank T (1996) Histologic progression of recurrent hepatitis C in liver transplant allografts. Am J Surg Pathol 20:731–738

    Article  PubMed  CAS  Google Scholar 

  • Haffner D, Cochat P, Otto G, Steffen H, Schaerer K (1995) When should isolated liver transplantation be performed in primary hyperoxaluria type 1? Follow-up report of two children. Nephrol Dial Transplant 10 [Suppl 8]:47–52

    Article  Google Scholar 

  • Hay J (1993) Bone disease in liver transplant recipients. Gastroenterol Clin North Am 22:337–349

    PubMed  CAS  Google Scholar 

  • Hood J, Koep L, Peters R et al (1980) Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med 302:272–275

    Article  PubMed  CAS  Google Scholar 

  • Karvountzis GG, Redeker AG (1974) Relation of alpha-feto-protein in acute hepatitis to severity and prognosis. Ann Intern Med 80:156–160

    PubMed  CAS  Google Scholar 

  • Krueger M, Tillmann HL, Trautwein C, Bode U, Oldhafer K, Maschek H, Boeker KH, Broelsch CE, Pichlmayr R, Manns MP (1996) Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Liver Transplant Surg 2:253–262

    Article  Google Scholar 

  • Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, Schmidt P, Pakrasi A, Artinian L, Murray NG, Imagawa DK, Holt C, Goldstein LI, Stribling R, Busuttil RW (1998) Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 28:585–589

    Article  PubMed  CAS  Google Scholar 

  • Markus B, Dickson E, Grambsch P (1989) Efficacy of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 320:1709–1713

    Article  PubMed  CAS  Google Scholar 

  • Marsh W, Dvorchik I, Subotin M, Balan V, Rakela J et al (1997) The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 26:444–450

    Article  PubMed  CAS  Google Scholar 

  • Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenta A (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699

    Article  PubMed  CAS  Google Scholar 

  • Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R (1991) Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut 32:1369–1373

    Article  PubMed  CAS  Google Scholar 

  • Nashan B, Schlitt H, Tusch G, Oldhafer K, Ringe B, Wagner S (1996) Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology 23:1105–1111

    Article  PubMed  CAS  Google Scholar 

  • O’Grady JG, Alexander GJ, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure (see comments). Gastroenterology 97:439–445

    PubMed  Google Scholar 

  • Osorio R, Ascher N, Avery M, Bacchetti P, Roberts J, Lake J (1994) Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 20:105–110

    PubMed  CAS  Google Scholar 

  • Perlmutter D (1991) The cellular basis for liver injury in alpha 1 antitrypsin deficiency. Hepatology 13:172–185

    Article  PubMed  CAS  Google Scholar 

  • Poynard T, Barthelmy P, Fratte S, Boudjema K, Doffoel M, Vaniemmens C (1994) Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet 344:502–507

    Article  PubMed  CAS  Google Scholar 

  • Rössle M, Siegerstetter V, Huber M, Ochs A (1998) The first decade of transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 18:73–89

    PubMed  Google Scholar 

  • Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E (1990) Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 25:119–126

    Article  PubMed  CAS  Google Scholar 

  • Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H (1993) Liver transplantation in European patients with the hepatitis B surface antigen (see comments). N Engl J Med 329:1842–1847

    Article  PubMed  CAS  Google Scholar 

  • Schluger L, Sheiner P, Thung S, Lau J, Min A, Wolf D (1996) Severe recurrent cholestatic hepatitis C following ortho-topic liver transplantation. Hepatology 23:971–976

    Article  PubMed  CAS  Google Scholar 

  • Shaked A, Colonna J, Goldstein L, Busuttil R (1992) The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 215:598–605

    Article  PubMed  CAS  Google Scholar 

  • Shakil AO, Dvorchik I, Fung JJ, Rakela J (1997) Liver transplantation for acute liver failure: outcome analysis. J Viral Hepatitis 4(Suppl 1):107–110

    Article  Google Scholar 

  • Shapiro J, Smith H, and Schaffner F (1979) Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 20:137–140

    Article  PubMed  CAS  Google Scholar 

  • Shetty K, Rybicki L, Carey W (1997) The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 25:1049–1053

    Article  PubMed  CAS  Google Scholar 

  • Sterneck M, Fischer L, Buggisch P, Malago M, Rogiers X, Burdelski M, Greten H, Broelsch CE (1996) Transplantation of complete and split liver grafts for patients with fulminant hepatic failure. German J Gastroenterol 34:795–800

    CAS  Google Scholar 

  • Sternlieb I (1990) Perspectives of Wilson’s disease. Hepatology 12:1234–1239

    Article  PubMed  CAS  Google Scholar 

  • Tang H, Boulton R, Gunson B, Hubscher S, Neuberger J (1998) Patterns of alcohol consumption after liver transplantation. Gut 43:140–145

    Article  PubMed  CAS  Google Scholar 

  • Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL (1996) Interferon alpha for recurrent hepatitis B infection after liver transplantation. Liver Transplant Surg 2:132–138

    Article  CAS  Google Scholar 

  • Trey C, Davidson C (1979) The management of fulminant hepatic failure. Prog Liver Dis 3:282–290

    Google Scholar 

  • Wiesner R, Grambsch P, Dickson E, Ludwig J, MacCarty R, Hunter E et al (1989) Primary sclerosing cholangitis: natural history, prognostic factors, and survival analysis. Hepatology 10:430–436

    Article  PubMed  CAS  Google Scholar 

  • Wright HI, Gavaler JS, Van Theil DH (1992) Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 53:121–124

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Kernklinik und Poliklinik, Universitätskrankenhaus Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany

    M. Sterneck MD

Authors
  1. M. Sterneck MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Radiologie, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany

    E. Bücheler MD (Professor) (Professor)

  2. Departments of Radiology and Nuclear Medicine, University Hospital Bergmannsheil Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Germany

    V. Nicolas MD (Professor) (Professor)

  3. Klinik und Poliklinik für Allgemeinchirurgie und Transplantationschirurgie, Universitätsklinik Essen, Hufelandstrasse 55, 45122, Essen, Germany

    C. E. Broelsch MD, FACS (Professor, Director) (Professor, Director)

  4. Klinik und Polyklinik für Chirurgie, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany

    X. Rogiers MD

  5. Klinik und Polyklinik für Radiologie, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany

    G. Krupski MD, PhD (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sterneck, M. (2003). Indications and General Pathology of Liver Transplantation Candidates. In: Bücheler, E., Nicolas, V., Broelsch, C.E., Rogiers, X., Krupski, G. (eds) Diagnostic and Interventional Radiology in Liver Transplantation. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55955-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55955-6_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62950-1

  • Online ISBN: 978-3-642-55955-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation